Analysis of the efficacy of splenic artery superselective embolization in cirrhosis with hepatocellular carcinoma.
<h4>Background</h4>To explore the safety and effectiveness of partial splenic embolization (PSE) in patients with hypersplenism and hepatocellular carcinoma (HCC) and to compare the efficacy of superselective and non-superselective embolization of splenic artery branches.<h4>Proced...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0323829 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849469953199046656 |
|---|---|
| author | Ke Zhao Hong-Tao Hu Hai-Liang Li Hong-Tao Cheng Ya-Nan Zhao Yuan Hang Quan-Jun Yao |
| author_facet | Ke Zhao Hong-Tao Hu Hai-Liang Li Hong-Tao Cheng Ya-Nan Zhao Yuan Hang Quan-Jun Yao |
| author_sort | Ke Zhao |
| collection | DOAJ |
| description | <h4>Background</h4>To explore the safety and effectiveness of partial splenic embolization (PSE) in patients with hypersplenism and hepatocellular carcinoma (HCC) and to compare the efficacy of superselective and non-superselective embolization of splenic artery branches.<h4>Procedure</h4>We retrospectively analyzed 64 patients with HCC who underwent PSE between August 2020 and December 2022. The patients were categorized into two groups based on different treatment plans: Group A (n=33) underwent superselective embolization and Group B (n=31) underwent non-superselective embolization of the splenic artery branches. The safety and effectiveness of the two methods were evaluated along with changes in peripheral blood cells [mainly white blood cells (WBC) and red blood cells (RBC)] and platelet (PLT) counts at different time points after PSE. Postoperative adverse events were also compared between the two groups.<h4>Results</h4>The technical success rate was 100% for both procedures. The PLT and WBC counts of the two groups significantly increased one week after PSE (P<0.05), and there was no statistically significant difference in the RBC count changes. At follow-up (4, 16, and 24 weeks), the PLT and WBC counts remained consistent at levels which were significantly different from those before PSE (P<0.05). However, the RBC counts were not significantly different (P>0.05). An independent sample t-test was used to compare the differences in blood counts between the two groups at the same time point. There were no statistically significant differences in PLT, WBC, and RBC counts between Group A and Group B at any time point after PSE (P>0.05). The incidence of fever and pain in Group B was significantly higher than that in Group A (P<0.05).<h4>Conclusion</h4>Partial splenic artery embolization is a safe and effective treatment option for hypersplenism. Both splenic artery branch superselective and non-superselective embolization strategies demonstrated comparable outcomes. However, superselective embolization exhibited a lower incidence of postprocedural complications than non-superselective embolization. |
| format | Article |
| id | doaj-art-940fc356bf7d48a38fcd59fc4604a458 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-940fc356bf7d48a38fcd59fc4604a4582025-08-20T03:25:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01205e032382910.1371/journal.pone.0323829Analysis of the efficacy of splenic artery superselective embolization in cirrhosis with hepatocellular carcinoma.Ke ZhaoHong-Tao HuHai-Liang LiHong-Tao ChengYa-Nan ZhaoYuan HangQuan-Jun Yao<h4>Background</h4>To explore the safety and effectiveness of partial splenic embolization (PSE) in patients with hypersplenism and hepatocellular carcinoma (HCC) and to compare the efficacy of superselective and non-superselective embolization of splenic artery branches.<h4>Procedure</h4>We retrospectively analyzed 64 patients with HCC who underwent PSE between August 2020 and December 2022. The patients were categorized into two groups based on different treatment plans: Group A (n=33) underwent superselective embolization and Group B (n=31) underwent non-superselective embolization of the splenic artery branches. The safety and effectiveness of the two methods were evaluated along with changes in peripheral blood cells [mainly white blood cells (WBC) and red blood cells (RBC)] and platelet (PLT) counts at different time points after PSE. Postoperative adverse events were also compared between the two groups.<h4>Results</h4>The technical success rate was 100% for both procedures. The PLT and WBC counts of the two groups significantly increased one week after PSE (P<0.05), and there was no statistically significant difference in the RBC count changes. At follow-up (4, 16, and 24 weeks), the PLT and WBC counts remained consistent at levels which were significantly different from those before PSE (P<0.05). However, the RBC counts were not significantly different (P>0.05). An independent sample t-test was used to compare the differences in blood counts between the two groups at the same time point. There were no statistically significant differences in PLT, WBC, and RBC counts between Group A and Group B at any time point after PSE (P>0.05). The incidence of fever and pain in Group B was significantly higher than that in Group A (P<0.05).<h4>Conclusion</h4>Partial splenic artery embolization is a safe and effective treatment option for hypersplenism. Both splenic artery branch superselective and non-superselective embolization strategies demonstrated comparable outcomes. However, superselective embolization exhibited a lower incidence of postprocedural complications than non-superselective embolization.https://doi.org/10.1371/journal.pone.0323829 |
| spellingShingle | Ke Zhao Hong-Tao Hu Hai-Liang Li Hong-Tao Cheng Ya-Nan Zhao Yuan Hang Quan-Jun Yao Analysis of the efficacy of splenic artery superselective embolization in cirrhosis with hepatocellular carcinoma. PLoS ONE |
| title | Analysis of the efficacy of splenic artery superselective embolization in cirrhosis with hepatocellular carcinoma. |
| title_full | Analysis of the efficacy of splenic artery superselective embolization in cirrhosis with hepatocellular carcinoma. |
| title_fullStr | Analysis of the efficacy of splenic artery superselective embolization in cirrhosis with hepatocellular carcinoma. |
| title_full_unstemmed | Analysis of the efficacy of splenic artery superselective embolization in cirrhosis with hepatocellular carcinoma. |
| title_short | Analysis of the efficacy of splenic artery superselective embolization in cirrhosis with hepatocellular carcinoma. |
| title_sort | analysis of the efficacy of splenic artery superselective embolization in cirrhosis with hepatocellular carcinoma |
| url | https://doi.org/10.1371/journal.pone.0323829 |
| work_keys_str_mv | AT kezhao analysisoftheefficacyofsplenicarterysuperselectiveembolizationincirrhosiswithhepatocellularcarcinoma AT hongtaohu analysisoftheefficacyofsplenicarterysuperselectiveembolizationincirrhosiswithhepatocellularcarcinoma AT hailiangli analysisoftheefficacyofsplenicarterysuperselectiveembolizationincirrhosiswithhepatocellularcarcinoma AT hongtaocheng analysisoftheefficacyofsplenicarterysuperselectiveembolizationincirrhosiswithhepatocellularcarcinoma AT yananzhao analysisoftheefficacyofsplenicarterysuperselectiveembolizationincirrhosiswithhepatocellularcarcinoma AT yuanhang analysisoftheefficacyofsplenicarterysuperselectiveembolizationincirrhosiswithhepatocellularcarcinoma AT quanjunyao analysisoftheefficacyofsplenicarterysuperselectiveembolizationincirrhosiswithhepatocellularcarcinoma |